301122.SHE Caina Technology Co. Ltd.
- Market cap
- CNY 6.05B
- P/E
- 449.7x
- P/B
- 3.19x
- ROE
- 1.1%
- Dividend yield
- 0.51%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301122.SHE undervalued?
Graham numberThe Graham number of Caina Technology Co. Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Caina Technology Co. Ltd. fundamental analysis
No fundamental analysis for Caina Technology Co. Ltd. yet.
Caina Technology Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Caina Technology Co. Ltd.
Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.
Full company profileCaina Technology Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Caina Technology Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 93.0M | 143M | 181M | 505M | 442M | 465M | 410M | 388M | 357M | 587M |
| Gross Profit | 32.6M | 49.9M | 73.1M | 242M | 194M | 190M | 151M | 116M | 79.8M | 142M |
| Operating Income | 12.7M | 21.8M | 40.7M | 163M | 152M | 180M | 129M | 57.5M | 3.22M | 21.7M |
| EBITDA | 24.7M | 37.4M | 59.0M | 182M | 173M | 211M | 162M | 95.6M | 57.0M | 20.9M |
| Net Income | 12.6M | 20.5M | 32.3M | 137M | 131M | 162M | 113M | 53.1M | 5.62M | 21.6M |
| EPS | 0.16 | 0.26 | 0.40 | 1.58 | 1.42 | 1.76 | 0.92 | 0.43 | 0.05 | 0.18 |
| Balance Sheet | ||||||||||
| Total Assets | 203M | 267M | 286M | 476M | 613M | 1.84B | 1.93B | 1.98B | 2.01B | 2.27B |
| Total Liabilities | 112M | 156M | 112M | 96.3M | 102M | 107M | 123M | 166M | 162M | 355M |
| Shareholders' Equity | 90.7M | 111M | 174M | 379M | 510M | 1.74B | 1.81B | 1.81B | 1.84B | 1.90B |
| Cash & Short-term Investments | 9.47M | 17.7M | 26.7M | 127M | 175M | 1.25B | 1.04B | 979M | 371M | 346M |
| Total Debt | 50.9M | 105M | 76.5M | 19.0M | 108K | 456K | 429K | 32.1M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 408K | 21.3M | 57.7M | 170M | 160M | 139M | 87.0M | 105M | 18.7M | - |
| Capital Expenditure | 33.8M | 19.8M | 48.8M | 72.2M | 97.2M | 165M | 198M | 102M | 92.7M | 104M |
| Free Cash Flow | -33.4M | 1.50M | 8.89M | 97.8M | 62.9M | -26.0M | -111M | 3.60M | -74.1M | -80.4M |
| Ratios | ||||||||||
| ROE | 13.9% | 18.4% | 18.6% | 36.1% | 25.6% | 9.3% | 6.2% | 2.9% | 0.3% | 1.1% |
| ROA | 6.2% | 7.7% | 11.3% | 28.8% | 21.3% | 8.8% | 5.8% | 2.7% | 0.3% | 1.0% |
| Net Profit Margin | 13.5% | 14.3% | 17.8% | 27.1% | 29.6% | 34.8% | 27.4% | 13.7% | 1.6% | 3.7% |
| Debt to Equity | 0.56x | 0.95x | 0.44x | 0.05x | 0.00x | 0.00x | 0.00x | 0.02x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Caina Technology Co. Ltd. dividends
- Dividend yield
- 0.51%
- Forward dividend
- 0.04 CNY
- Payout ratio
- 543.7%
- Ex-dividend date
- Jun 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 30.6M | 0.25 | 543.7% |
| 2024 | CNY 48.9M | 0.40 | 92.1% |
| 2023 | CNY 42.3M | 0.35 | 37.6% |
| 2022 | CNY 32.9M | 0.36 | 20.3% |
| 2021 | CNY 264K | 0.00 | 0.2% |
| 2020 | CNY 23.7M | 0.27 | 17.3% |
| 2019 | CNY 5.49M | 0.07 | 17.0% |
| 2018 | 4.85M | 0.06 | 23.6% |
| 2017 | 2.89M | 0.04 | 22.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on May 16, 2023.
Who owns Caina Technology Co. Ltd.
- Insiders 67.76%
- Institutions 4.56%
- Public & others 27.68%
- Shares outstanding 122M
- Free float 33.0M
Caina Technology Co. Ltd. company profile
- Company name
- Caina Technology Co. Ltd.
- Ticker
- 301122.SHE
- ISIN
- CNE1000056T2
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,057
- Fiscal year end
- December
- Address
- No. 253, Chenglu Road, Jiangyin, China, 214421
- Phone
- 86 10 8639 6766
- Website
- caina.ltd
About Caina Technology Co. Ltd.
Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.
Caina Technology Co. Ltd. management
5- Mr. Jun LuChairman & GM · born 1971
- Ms. Lingyun ZhaAccounting Supervisor, CFO & Director · born 1972
- Ms. Hong ZhaoDeputy GM & Director · born 1974
- Mr. Lijie ZhaoDeputy GM & Employee Representative Director · born 1982
- Mr. Weiwei LuBoard Secretary · born 1994